I-Mab
NASDAQ:NBP
I-Mab
NASDAQ:NBP
Price:
3.505
USD
0.14%
Market Cap:
$404m
Relative Value
The Relative Value of one
NBP
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 3.505 USD,
I-Mab
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NBP Relative Value
HIDDEN
Multiples Across Competitors
NBP Competitors Multiples
I-Mab Competitors
I-Mab Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
I-Mab
NASDAQ:NBP
|
404m USD | 0 | -16.8 | -5.1 | -5.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
402.1B USD | 6.6 | 96.5 | 15.8 | 22 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.2B USD | 5.5 | 26.2 | 15 | 15 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
182B USD | 6.3 | 21.6 | 13.5 | 16.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
117.1B USD | 10.7 | 32.5 | 24.6 | 25.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.6B USD | 5.7 | 18.3 | 13.8 | 15.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69.4B AUD | 3.2 | 35.2 | 11.6 | 14.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.3B EUR | 11.1 | 35.7 | 38.8 | 39.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
